SCHEMBL13615829

SCHEMBL13615829

c1ccc([Si](c2ccccc2)(c2ccccc2)c2ccc(-c3ccc4c5ccccc5c5c6cc(-c7ccc([Si](c8ccccc8)(c8ccccc8)c8ccccc8)cc7)ccc6c6ccccc6c5c4c3)cc2)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JAK2 O60674 2/20 0.35
TRIM58 Q8NG06 1/20 0.35
DHFR P00374 1/20 0.34
MAP4K4 O95819 1/20 0.34
PRMT5 O14744 1/20 0.33
MKNK1 Q9BUB5 1/20 0.33
ESR2 Q92731 1/20 0.32
PLAU P00749 1/20 0.32
PIK3CA P42336 1/20 0.32
ALOX5 P09917 1/20 0.31
PLA2G2A P14555 1/20 0.31
PLA2G4A P47712 1/20 0.31
ALK Q9UM73 1/20 0.31
IMPDH2 P12268 1/20 0.31
CCNE2 O96020 1/20 0.31
CDK4 P11802 1/20 0.31
CCND1 P24385 1/20 0.31
CCNE1 P24864 1/20 0.31
CDK2 P24941 1/20 0.31
CHEK1 O14757 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16303792 0.90 JAK2 (0.38) JAK2TRIM58DHFRMAP4K4PRMT5
SCHEMBL24742412 0.88 JAK2 (0.33) JAK2DHFRMAP4K4PRMT5MKNK1
SCHEMBL13615943 0.86 CYP1A2 (0.33) ALDH1A1CYP1A2THRBHPGDHSD17B10
SCHEMBL13615760 0.86 CYP1A2 (0.33) ALDH1A1CYP1A2THRBHPGDHSD17B10
SCHEMBL16303789 0.85 JAK2 (0.39) JAK2TRIM58DHFRMAP4K4PRMT5
SCHEMBL13615820 0.81 TRIM58 (0.35) JAK2TRIM58DHFRMAP4K4PLA2G2A
SCHEMBL17083517 0.81 JAK2 (0.37) JAK2TRIM58DHFRMAP4K4ESR2
SCHEMBL24169618 0.80 MEN1 (0.41) JAK2TRIM58DHFRALDH1A1HPGD
SCHEMBL26573474 0.80 MEN1 (0.41) JAK2TRIM58DHFRALDH1A1HPGD
SCHEMBL26573606 0.78 MEN1 (0.40) JAK2TRIM58DHFRALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090273278-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2009-11-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090273278-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same OCIAD1, OCIAD2, ORMDL3 JAK2 4018/4885TRIM58 4434/4885DHFR 1993/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.